文献速递脊髓损伤康复心肺康复

阿布特罗缓释片对慢性脊髓损伤患者肺功能的影响

Effect of Albuterol Repetabs on Pulmonary Function in Individuals With Chronic Spinal Cord Injury.
PubMed 文献 · Arch Phys Med Rehabil · 2026-01-24

这项为期12周的前瞻性双盲安慰剂对照试验纳入32例慢性脊髓损伤患者,评估每日两次阿布特罗缓释片对肺功能的影响。结果显示,与安慰剂相比,阿布特罗组在肺总容量、肺活量、呼气储备量和最大吸气压力方面均有改善,且呼气储备量和用力呼气量存在交互效应。

要点

  • 阿布特罗缓释片每日两次治疗12周可改善慢性脊髓损伤患者的总体肺功能和通气肌力。
  • 药物组肺总容量、肺活量、呼气储备量和最大吸气压力均改善。
  • 药物组第一秒用力呼气量无变化,安慰剂组呈显著下降趋势。

核心结论

  • 与安慰剂相比,12周阿布特罗治疗改善了脊髓损伤患者的总体肺功能和通气肌力。

研究设计与样本

  • 为期12周的前瞻性、双盲、安慰剂对照试验,共纳入32例慢性脊髓损伤患者。
  • 干预为阿布特罗缓释片或安慰剂,每日两次,持续12周。
  • 主要结局指标为肺功能测试及最大吸气和呼气压力。

主要发现

  • 呼气储备量和用力呼气量存在交互效应。
  • 药物组在肺总容量、肺活量、呼气储备量和最大吸气压力方面均有改善。
  • 药物组第一秒用力呼气量无变化,安慰剂组呈显著下降趋势。

临床怎么用

  • 对于慢性脊髓损伤患者,可考虑使用阿布特罗缓释片每日两次、持续12周以改善肺功能和通气肌力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the effect of 12 weeks of twice daily albuterol repetabs on pulmonary function in persons with chronic spinal cord injury. DESIGN: Twelve-week prospective, double-blinded, placebo-controlled trial. SETTING: Research laboratories. PARTICIPANTS: Thirty two individuals (N=32) with chronic spinal cord injury. INTERVENTIONS: Albuterol repetabs or placebo, twice daily, for 12 weeks. MAIN OUTCOME MEASURES: Pulmonary function tests and maximum inspiratory and expiratory pressures. RESULTS: Interaction effects were found for expiratory reserve volume and forced expiratory volume. Improvements in the drug group were found for total lung capacity, vital capacity, expiratory reserve volume, and maximal inspiratory pressure. Forced expiratory volume in 1 second did not change in the drug group but trended toward a significant decrease in the placebo group. CONCLUSIONS: Twelve weeks of albuterol treatment improved overall pulmonary function and ventilatory muscle strength, compared to placebo, in those living with spinal cord injury.

来源:Arch Phys Med Rehabil,查看原文。版权归原作者所有。

引用

  1. Panza GS, La Fountaine MF, Sutor TW, et al. Effect of Albuterol Repetabs on Pulmonary Function in Individuals With Chronic Spinal Cord Injury. Arch Phys Med Rehabil. 2026. PMID: 41587730. doi:10.1016/j.apmr.2026.01.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。